Table 2.
Prognostic factors of overall survival in propensity score-matched pairs
| Factors | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
| HR (95% CI) | P | HR (95% CI) | P | |
| Age | 0.996 (0.977~1.015) | 0.657 | ||
| Gender (male) | 1.709 (0.874~3.340) | 0.117 | ||
| TBIL | 0.996 (0.961~1.033) | 0.844 | ||
| ALT | 1.004 (0.999~1.009) | 0.160 | ||
| AST | 1.002 (0.996~1.009) | 0.484 | ||
| ALB | 0.969 (0.920~1.021) | 0.241 | ||
| PT | 0.969 (0.795~1.181) | 0.757 | ||
| CREA | 1.019 (1.004~1.034) | 0.012 | 1.014 (1.002~1.027) | 0.025 |
| AFP (> 400 ng/mL) | 1.421 (0.890~2.269) | 0.141 | ||
| Tumor size (3~5 cm) | 1.326 (0.850~2.069) | 0.214 | ||
| Tumor number (2~3) | 2.214 (1.114~4.399) | 0.023 | ||
| Transfusion (+) | 1.539 (0.597~3.968) | 0.372 | ||
| Cirrhosis (+) | 1.136 (0.471~2.741) | 0.777 | ||
| MVI (+) | 3.432 (2.040~5.773) | < 0.001 | 2.628 (1.759~3.925) | < 0.001 |
| Poor differentiation (+) | 3.579 (2.251~5.691) | < 0.001 | ||
| PLT (< 100 × 109/L) | 1.592 (1.016~2.493) | 0.042 | ||
HR hazard ratio, CI confidence interval, TBIL total bilirubin, ALT alanine aminotransferase, AST aspartate aminotransferase, ALB albumin, PT prothrombin time, CREA creatinine, AFP alpha-fetoprotein, MVI microvascular invasion, PLT platelet counts